---
schema_version: "secwatch.filing_event.v1"
accession: "0000313143-22-000045"
form_type: "8-K"
ticker: "HAE"
cik: "0000313143"
company_name: "HAEMONETICS CORP"
filed_at: "2022-08-08T23:59:59+00:00"
generated_at: "2026-06-24T03:03:32.152811+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "medium"
source: SEC EDGAR
---

# Haemonetics names CFO James D'Arecca as principal accounting officer following controller's departure

## Summary
- James C. D'Arecca, EVP/CFO, assumes principal accounting officer role effective Aug 5, 2022, replacing departing controller Dan Goldstein.
- 2022 annual meeting held Aug 5 with 94.1% quorum; all nine director nominees elected with majority support.
- Shareholders approved say-on-pay (43.98M for, 2.71M against) and ratified Ernst & Young as auditor (47.09M for, 1.16M against).
- Vote totals show high approval for most directors; Charles Dockendorff and Ellen Zane received the most withhold votes at 5.96M and 3.27M, respectively.

## SEC filing metadata
- accession: 0000313143-22-000045
- form_type: 8-K
- ticker: HAE
- cik: 0000313143
- company_name: HAEMONETICS CORP
- filed_at: 2022-08-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: medium
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/313143/000031314322000045/0000313143-22-000045-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/313143/000031314322000045/hae-20220805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000313143-22-000045
- JSON: https://secwatch.observer/filing/0000313143-22-000045.json
- Plain text: https://secwatch.observer/filing/0000313143-22-000045.txt

## Key facts
- Executive change
  James C. D'Arecca was appointed as principal accounting officer at HAEMONETICS CORP.
  - Action: appointed
  - Role: principal accounting officer
  source text: On August 5, 2022, the Board of Directors of Haemonetics Corporation (the “Company”) appointed James C. D’Arecca, Executive Vice President, Chief Financial Officer, as the Company’s principal accounting officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/313143/000031314322000045/0000313143-22-000045-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.